• Forum
  • Stock Markets
    • MarketsLive prices, indices, and market performance
    • Stock CalendarUpcoming earnings, listings, and corporate events
    • Dividends CalendarFuture and past dividends
  • Companies
    • CompaniesBrowse and filter the full list of listed companies
    • DiscoveryInspiration for your next investment
    • IPOsNew listings and upcoming public offerings
    • AGM InvitationsAnnual general meeting dates and shareholder info
  • Stock Research
    • ResearchExpert stock analysis and recommendations
    • ArticlesNews, insights, and market commentary
    • inderesTVVideo hub for stock research, analysis, and expert commentary
    • TranscriptsFull text records of earnings calls and investor meetings
    • Stock ComparisonCompare financials and performance across multiple stocks
    • Earnings SeasonCompare EPS estimates to reported results
    • Compound Interest CalculatorSee how your savings grow with the power of compound interest.
Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • X (Twitter)
Get in touch
  • info@hcandersencapital.dk
  • Bredgade 23B, 2. sal
    1260 København K
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer

Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.

Medicortex International

1.50 SEK0.00 %24.7, 17.27
Less than 1K followers

MEDFIN B

NGM Growth Market

Medical Equipment & Services

Health Care

Overview
Financials & Estimates
Ownership
Dividend
Investor consensus
Compare
0.00 %
-38.78 %
-43.40 %
-49.15 %
-53.99 %
-59.35 %
-97.28 %
-98.81 %
-99.07 %

Medicortex International is a medical technology company that develops diagnostic solutions for traumatic brain injuries, with a focus on biomarker-based tests. The company conducts research and development with the goal of enabling rapid and accessible diagnostics and works long-term with the development of treatment solutions. The business has an international focus.

Read more
Market cap
35M SEK
Turnover
2.02K SEK
Revenue
4.98M
EBIT %
-117.87 %
P/E
-
Dividend yield-%
-
Revenue and EBIT-%
EPS and dividend
Financial calendar
28.8
2026

Interim report Q2'26

All
Press releases
3rd party
ShowingAll content types

Revenue and EBIT-%

Revenue M

EBIT-% (adj.)

EPS and dividend

EPS (adj.)

Dividend %

Regulatory press release06.07.2026, 09.05

CEO Letter: Leading the Future of Brain Injury Diagnostics

Medicortex International
Third party research11.09.2023, 14.43

Nosium: Nya målsättningar att sikta mot - Analyst Group

Under de senaste månaderna har NOSIUM kommunicerat flera nyheter och det är tydligt att aktiviteten kring bolaget är fortsatt hög. Vid utgången av årets andra kvartal bestod NOSIUM:s portfölj av totalt 14 innehav och med hänsyn till senast aktuell information...

Medicortex International

Join Inderes community

Don't miss out - create an account and get all the possible benefits

Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools
Create account